Kestra Medical Technologies, Ltd. (KMTS) Return on equity 2025–2026
Kestra Medical Technologies, Ltd. (KMTS) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-50.7%FY2026 · since FY2025: -55.4% → -50.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -50.7% | +4.7 pp |
| FY2025 | -55.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More KMTS financial trends
KMTS RevenueKMTS Net incomeKMTS Net marginKMTS Gross profitKMTS Gross marginKMTS Operating incomeKMTS Operating marginKMTS Operating cash flowKMTS Free cash flowKMTS Capital expendituresKMTS Stock buybacksKMTS Dividends paidKMTS Total assetsKMTS Total liabilitiesKMTS Shareholders’ equityKMTS overview →